Article
Recent Developments in Recombinant AAV-Mediated Gene Therapy for Lung Diseases
1 Jun 2005
Abstract excerpt
Recent studies have shed light on a number of important obstacles to safe and effective gene transfer to the respiratory tract with recombinant AAV vectors. Among these are blocks at the level of receptor binding and internalizations, evasion of proteasomal degradation, inefficiency of nuclear entry, and nuclear factors that inhibit the conversion of rAAV genomes into active double-stranded DNA form. Other...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
